D.E. Shaw & Co
PDSB icon

D.E. Shaw & Co’s PDS Biotechnology PDSB Stock Holding History

D.E. Shaw & Co’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-49,695
Closed -$247K – 4635
2023
Q4 		$247K Buy
+49,695
New +$247K ﹤0.01% 3814
2023
Q2 		– Sell
-162,769
Closed -$1M – 4470
2023
Q1 		$1M Sell
162,769
-176,909
-52% -$1.45M ﹤0.01% 3165
2022
Q4 		$4.48M Buy
339,678
+324,774
+2,179% +$2.29M 0.01% 2204
2022
Q3 		$44K Buy
+14,904
New +$63.2K ﹤0.01% 4703
2022
Q2 		– Sell
-83,112
Closed -$514K – 5663
2022
Q1 		$514K Buy
83,112
+53,507
+181% +$332K ﹤0.01% 4355
2021
Q4 		$240K Buy
+29,605
New +$319K ﹤0.01% 4791
2020
Q2 		– Sell
-13,281
Closed -$10K – 4203
2020
Q1 		$10K Hold
13,281
– – ﹤0.01% 3866
2019
Q4 		$35K Sell
13,281
-397
-3% -$1.13K ﹤0.01% 3905
2019
Q3 		$46K Hold
13,678
– – ﹤0.01% 3730
2019
Q2 		$82K Sell
13,678
-25,256
-65% -$165K ﹤0.01% 3563
2019
Q1 		$288K Buy
38,934
+1,746
+5% +$14.6K ﹤0.01% 3237
2018
Q4 		$238K Sell
37,188
-798
-2% -$10.6K ﹤0.01% 3468
2018
Q3 		$623K Sell
37,986
-4,847
-11% -$87.1K ﹤0.01% 2978
2018
Q2 		$883K Buy
42,833
+41,085
+2,350% +$857K ﹤0.01% 2775
2018
Q1 		$41K Buy
1,748
+292
+20% +$78.5K ﹤0.01% 3431
2017
Q4 		$273K Buy
1,456
+170
+13% +$34.2K ﹤0.01% 3279
2017
Q3 		$276K Buy
1,286
+135
+12% +$27.9K ﹤0.01% 3176
2017
Q2 		$236K Sell
1,151
-256
-18% -$50.4K ﹤0.01% 3132
2017
Q1 		$256K Buy
1,407
+498
+55% +$98.6K ﹤0.01% 3034
2016
Q4 		$227K Buy
+909
New +$207K ﹤0.01% 3226
2016
Q2 		– Sell
-613
Closed -$112K – 3483
2016
Q1 		$112K Sell
613
-1,100
-64% -$197K ﹤0.01% 3274
2015
Q4 		$428K Buy
+1,713
New +$552K ﹤0.01% 3173

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

D.E. Shaw & Co's PDSB Position: Q1 2024 in Review

D.E. Shaw & Co sold out of PDS Biotechnology (PDSB) in Q1 2024, closing a stake of 49,695 shares — an estimated $247K sold.

D.E. Shaw & Co first reported a position in PDSB in Q4 2015 and held it in 22 quarters. The position peaked at $4.48M in Q4 2022. 72 funds tracked by Wall St. Rank hold PDSB as of Q1 2024.

  • D.E. Shaw & Co reported no remaining PDS Biotechnology position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 49,695 PDS Biotechnology shares in Q1 2024, an estimated $247K.
  • D.E. Shaw & Co first reported a position in PDS Biotechnology in Q4 2015 and held it in 22 quarters.
  • D.E. Shaw & Co's PDS Biotechnology position peaked at $4.48M in Q4 2022.
  • 72 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.